omtiti
JF-Expert Member
- Jun 19, 2019
- 1,022
- 1,591
Kama hatuwezi kutengeneza ndio tudungwe sumu?
Kama hatuwezi kutengeneza ndio tudungwe sumu?Waafrika sisi ni matahira,sasa unalaumu we we mwenyewe na Nchi yako hamuwezi kutengeza hata kidonge.
sikiliza hizo video mbili kama kweli unataka uthibitisho. najua hizi bado kwa sceptic si uthibitisho lakini ni mwanzo wa safari ya kusaka uthibitishoThibitisha sio chanjo, na leta chanjo yako
watu wenye fikra za kirushwarushwa mna matatizo sana....yaani WHO wameapprove chanjo feki na wameanza kuchanja watu wao wenyewe zaidi ya 200mil western europe? hata viwanja vya michezo wamefungulia vinajaa mashabiki!!!
marekani imeshachanja zaidi ya watu 170mil....kisha wewe mnywa viroba unakuja na hoja ya kijinga kama hii.
jifunze kushughulisha ubongo wako. Huyo gwajima mnayemsikiliza ni form four failure tu. Hana hata diploma moja. Hiyo Phd yake ni feki kutoka chuo feki which doesnot exists kinaitwa Omega global university.
Ni aibu wasomi wa tz mnamsikiliza mtu mwenye elimu ya msingi ambaye research zake zimebase katika kutazama video clips za TIKTOK na ninyi elimu zenu mmeziweka chini ya makalio yenu.
Tofauti na Gwajima ni kuwa Dr Zelenko ametibu maelfu ya wagonjwa wa covid 19 na wakapona.Sasa huyu DR. Vladmir Zalenko na Gwajima wanautofauti gani Mkuu????Msome hapa
Dr. Vladimir Zelenko, the man behind a treatment regimen involving the antimalarial drug hydroxychloroquine adopted by President Donald Trump, said in an undated interview with an Israeli rabbinical leader that people like George Soros and Bill Gates are involved in a “war against God” designed to “maintain global fear” as a part of an effort to “reorganize the social structure and fabric of the world.”
“There are properties in this vaccine which may inhibit fertility for young girls,” Zelenko said, without evidence, to Rabbi Amnon Yitzhak. “Also, there’s small particles called nanoparticles in this vaccine that may have the ability to track someone. In other words, with the increasing satellite networks, it may be very possible to have a GPS inside of every person.”
There is no evidence to suggest that vaccine manufacturers will attempt to track patients’ locations, and the coronavirus vaccine does not cause infertility.
Hasidic doctor spouts conspiracy theories, anti-vaccine sentiment in video
Dr. Vladimir Zelenko, the man behind a treatment regimen involving hydroxychloroquine, espoused baseless anti-vaccine and conspiracist views.forward.com
Dr. Zelenko attended Capitol Trump rally and hoped to avoid “too much collateral damage”
Tofauti na Gwajima ni kuwa Dr Zelenko ametibu maelfu ya wagonjwa wa covid 19 na wakapona.
Vijana wengi Tanzania wana mentality za kijinga sana kuliko hata wazee,kuna mtu hapa anauliza kwann baadhi ya chanzo watu hawajazi consent form, Like seriously? Mtu anashindwa kujishughulisha kiakili kutambua evolution ya chanjo duniani na why baadhi ya chanjo zilifika kipindi zikawa mandatory. Vaccines mbalimbali zilizotengenezwa duniani,at the earliest watu walikuwa wanajaza consent forms as a matter of procedures,lakini zilipokuja kuwa mandatory-consent forms umuhimu wake ukaondoka sababu chanjo ilikuwa ni lazima.Consent form inakupa option ya ku-reject au accept,but inapokuwa mandatory-mtu anaondolewa option ya ku-reject.Sasa huyu DR. Vladmir Zalenko na Gwajima wanautofauti gani Mkuu????Msome hapa
Dr. Vladimir Zelenko, the man behind a treatment regimen involving the antimalarial drug hydroxychloroquine adopted by President Donald Trump, said in an undated interview with an Israeli rabbinical leader that people like George Soros and Bill Gates are involved in a “war against God” designed to “maintain global fear” as a part of an effort to “reorganize the social structure and fabric of the world.”
“There are properties in this vaccine which may inhibit fertility for young girls,” Zelenko said, without evidence, to Rabbi Amnon Yitzhak. “Also, there’s small particles called nanoparticles in this vaccine that may have the ability to track someone. In other words, with the increasing satellite networks, it may be very possible to have a GPS inside of every person.”
There is no evidence to suggest that vaccine manufacturers will attempt to track patients’ locations, and the coronavirus vaccine does not cause infertility.
Hasidic doctor spouts conspiracy theories, anti-vaccine sentiment in video
Dr. Vladimir Zelenko, the man behind a treatment regimen involving hydroxychloroquine, espoused baseless anti-vaccine and conspiracist views.forward.com
Dr. Zelenko attended Capitol Trump rally and hoped to avoid “too much collateral damage”
Hilo nalo lina ukweli maana hizo zilikuwa chanjo lakini hii si chanjo bali ni gene therapy.View attachment 1916328
Ndio yale yale, vaccine ya Polio, Tetanus hazina WAR AGAINST GOD ila covaxxxx???????? 😀 😀 😀
Hakuna chanjo isiyofanya genes alteration labda kama ni dawaHilo nalo lina ukweli maana hizo zilikuwa chanjo lakini hii si chanjo bali ni gene therapy.
Ndiyo mkubari kuwa ni chanjo ya majaribioChanjo zote za COVID zimeidhinishwa na WHO kwaajili ya matumizi ya dharula kwasababu maisha ya watu yanapotea na shughuli za kiuchumi nyingi zilisimama.
Na bahati nzuri zimepunguza vifo kwa kiasi kikubwa sana.
thibitishaHakuna chanjo isiyofanya genes alteration labda kama ni dawa
Elewa maana ya dharuraUnafikiri WHO ni malaika?,fahamu hao ni binadamu wana mapungufu pia,wana interest zao,wananunulika ,wanaweza kiuka viapo vyao.
Remember hakuna mkate mgumu mbele ya chai
Nachoelewa mimi kwendana na literature mbalimbali zikiwemo Scientific journals pamoja na sheria tofauti tofauti duniani-To date,chanjo yeyote inayoweza kupelekea kubadilisha genetic make-up ya binadamu ni totally prohibited
Kazi ya 1998,
Abstract
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy. This is due to the economic reality of making vaccines for human use. Genetically engineered subunit vaccines are more costly to manufacture than conventional vaccines, since the antigen must be purified to a higher standard than was demanded of older, conventional vaccines. Each vaccine must also be subjected to extensive testing and review by the FDA, as it would be considered a new product. This is costly to a company in terms of both time and money and is unnecessary if a licensed product is already on the market. Although recombinant subunit vaccines hold great promise, they do present some potential limitations. In addition to being less reactogenic, recombinant subunit vaccines have a tendency to be less immunogenic than their conventional counterparts. This can be attributed to these vaccines being held to a higher degree of purity than was traditionally done for an earlier generation of licensed subunit vaccines. Ironically, the contaminants often found in conventional subunit vaccines may have aided in the inflammatory process, which is essential for initiating a vigorous immune response. This potential problem may be overcome by employing one of the many new types of adjuvants that are becoming available for use in humans. Recombinant subunit vaccines may also suffer from being too well-defined, because they are composed of a single antigen. In contrast, conventional vaccines contain trace amounts of other antigens that may aid in conferring an immunity to infectious agents that is more solid than could be provided by a monovalent vaccine. This problem can be minimized, where necessary, by creating recombinant vaccines that are composed of multiple antigens from the same pathogen. These issues are less of a concern with a live attenuated vaccine, since these vaccines are less costly, require fewer steps to manufacture, and elicit long-lived immunity after only a single dose. Unfortunately, live vaccines carry a higher risk of vaccine-induced complications in recipients that make their use in highly developed, litiginous countries unlikely. In lesser developed countries, where the prevalence of disease and the need for effective vaccines outweighs the risk associated with their administration, live vaccines may play an important role in human health. This review has attempted to make the reader aware of some of the current approaches and issues that are associated with the development of these vaccines. Genetically engineered vaccines hold great promise for the future, but the potential of these vaccines to improve human and animal health has yet to be fully realized.
Genetically engineered vaccines: an overview - PubMed
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy...pubmed.ncbi.nlm.nih.gov
China walifanya nini mkuu?Gwajima unakukwaza nini,labda tuanzie hapo - Gwajima anacho sema kinahusu mfumo uliyo tumika kuzalisha chanjo - mfumo huo una walakini sana, wala uhitaji shahada ya PhD ya fani ya Molecular Biology na Immunology to know matatizo ya muda mfupi na muda mrefu yanayo weza kusababishwa na hizi Experimental Biological Agents - wao wanaziita chanjo!! Bone of contention ya Gwajima na mRNA na Vector chanjo ni genetic technology ambayo inetumiwa kuzakisha chanjo badala ya kutumia njia asili ya kuzalisha chanjo ambayo sehemu ya kirusi cha covid kilicho punguzwa nguvu au kuharibiwa kabisa ndio vinatumiwa kuzalisha chanjo bila ya kuongeza kitu cha ziada - chanjo ambazo Gwajima anazipinga ni hizi ambazo hazina ingredient yoyote ya covid bali wao wanaingiza vitu ambavyo sio native wa virusi vya covid! Hapo Dunia itegemee nini?Kwa nini tushangae injuries zinazo sababishwa na chanjo hizi za mRNA na za Vector type - injuries kama: blood clot, stroke,paralysis, kuvimba moyo au ubongo,kuharibu ovaries za kina mama nk - halafu tuseme hivi ni vitu vya kawaida kweli?
Mbona mambo hayo hatuyasikii kwenye chanjo za Kichina zinazo tumiwa kwenye mataifa 60 Duniani ikiwemo uchina yenyewe iliyo chanja RAIA wake zaidi ya 1.2 billion - kumbuka chanjo za kichina zinazalishwa kwa njia ya asilini na kama nilivyo sema hapo juu, Chanjo za Kichina hazina madhala kwa sababu mbinu zilizo tumiwa kuzalisha chanjo ndio mbinu zilizo vumbuliwa zaidi ya miaka mia iliyo pita ndio utumiwa kuzalisha chanjo za: Ndui,yellow fever,measles, pepo punda,TB no - ni tested and proven technology.
Zanzibar wanadunga watu wao kwa chanjo zinazo toka Uchina, sasa kwa nini Tanzania bara tusiwe na choice ya kuchagua chanjo ambayo RAIA anaona itakuwa balabala/faa kwake.
Kinacho shangaza kwa nini Dunia haitaki kujifunza kutoka Uchina jinsi ya kudhibiti na kuondoa kabisa tatizo hili la covid variant zote - tangu chanjo hizi za kijinetiki zianze kutumika Merikani na Ulaya mbona maambukizi yanaongezeka badala ya kupungua ni as if chanjo zenyewe zina wafanya baadhi ya watu walio chanjwa kuwa fast breeder wa covid variant kama vile fast breeder nuclear teactors, kwa nini baadhi ya majibo ya Merikani yaliko hitikia kwa wingi chanjo ndio yanaongoza kwa maambukizi - what does that tell you - kuna matatizo si bure.
Bottom line is: Maoni ya Gwajima sio ya kubezwa bezwa hata kidogo, tuombe uhai lakini kadri siku/miaka inavyo kwenda tutakuja kumkumbuka Gwajima mapungufu yake notwithstanding.
Pamoja na evolution ya science ikiwemo massive funding ambayo imekuwa invested ku-speed vaccines discovery.Elewa maana ya dharura
Hivi unaweza kupoteza muda wako kumjibu Gwajima! labda asiyemfahamu ( Treni, Vijana kuwapeleka ulaya, nk.) Labda watu wa aina ya sabato masalia wanaweza kujaribuGwajima Yuko Sasa ndiyo maana hakuna mwanasayansi aliyetokea mpaka kujibu maswali ya Gwajima,hata Ile tume ya Corona wamekimbia.
Na wanaojitutumua kumjibu Sana Sana wanaishia kusema anapotosha tu.
Hata hiyo Genes therapy unayosema ipo kwenye COVAXX sio sahihi, ila wadau wanadai ndio itakuwa future ya vaccine zijazo,
Kazi ya 1998,
Abstract
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy. This is due to the economic reality of making vaccines for human use. Genetically engineered subunit vaccines are more costly to manufacture than conventional vaccines, since the antigen must be purified to a higher standard than was demanded of older, conventional vaccines. Each vaccine must also be subjected to extensive testing and review by the FDA, as it would be considered a new product. This is costly to a company in terms of both time and money and is unnecessary if a licensed product is already on the market. Although recombinant subunit vaccines hold great promise, they do present some potential limitations. In addition to being less reactogenic, recombinant subunit vaccines have a tendency to be less immunogenic than their conventional counterparts. This can be attributed to these vaccines being held to a higher degree of purity than was traditionally done for an earlier generation of licensed subunit vaccines. Ironically, the contaminants often found in conventional subunit vaccines may have aided in the inflammatory process, which is essential for initiating a vigorous immune response. This potential problem may be overcome by employing one of the many new types of adjuvants that are becoming available for use in humans. Recombinant subunit vaccines may also suffer from being too well-defined, because they are composed of a single antigen. In contrast, conventional vaccines contain trace amounts of other antigens that may aid in conferring an immunity to infectious agents that is more solid than could be provided by a monovalent vaccine. This problem can be minimized, where necessary, by creating recombinant vaccines that are composed of multiple antigens from the same pathogen. These issues are less of a concern with a live attenuated vaccine, since these vaccines are less costly, require fewer steps to manufacture, and elicit long-lived immunity after only a single dose. Unfortunately, live vaccines carry a higher risk of vaccine-induced complications in recipients that make their use in highly developed, litiginous countries unlikely. In lesser developed countries, where the prevalence of disease and the need for effective vaccines outweighs the risk associated with their administration, live vaccines may play an important role in human health. This review has attempted to make the reader aware of some of the current approaches and issues that are associated with the development of these vaccines. Genetically engineered vaccines hold great promise for the future, but the potential of these vaccines to improve human and animal health has yet to be fully realized.
Genetically engineered vaccines: an overview - PubMed
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy...pubmed.ncbi.nlm.nih.gov
Bila shaka si malaika, angalau ni wataalamu wanaoelewa wanachoongelea. Kinyume na wengine "wenye kitu ndani"Unafikiri WHO ni malaika?,fahamu hao ni binadamu wana mapungufu pia,wana interest zao,wananunulika ,wanaweza kiuka viapo vyao.
Remember hakuna mkate mgumu mbele ya chai
nisome section gani - kwenye abstract kote hakuna ulichokisema.
Kazi ya 1998,
Abstract
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy. This is due to the economic reality of making vaccines for human use. Genetically engineered subunit vaccines are more costly to manufacture than conventional vaccines, since the antigen must be purified to a higher standard than was demanded of older, conventional vaccines. Each vaccine must also be subjected to extensive testing and review by the FDA, as it would be considered a new product. This is costly to a company in terms of both time and money and is unnecessary if a licensed product is already on the market. Although recombinant subunit vaccines hold great promise, they do present some potential limitations. In addition to being less reactogenic, recombinant subunit vaccines have a tendency to be less immunogenic than their conventional counterparts. This can be attributed to these vaccines being held to a higher degree of purity than was traditionally done for an earlier generation of licensed subunit vaccines. Ironically, the contaminants often found in conventional subunit vaccines may have aided in the inflammatory process, which is essential for initiating a vigorous immune response. This potential problem may be overcome by employing one of the many new types of adjuvants that are becoming available for use in humans. Recombinant subunit vaccines may also suffer from being too well-defined, because they are composed of a single antigen. In contrast, conventional vaccines contain trace amounts of other antigens that may aid in conferring an immunity to infectious agents that is more solid than could be provided by a monovalent vaccine. This problem can be minimized, where necessary, by creating recombinant vaccines that are composed of multiple antigens from the same pathogen. These issues are less of a concern with a live attenuated vaccine, since these vaccines are less costly, require fewer steps to manufacture, and elicit long-lived immunity after only a single dose. Unfortunately, live vaccines carry a higher risk of vaccine-induced complications in recipients that make their use in highly developed, litiginous countries unlikely. In lesser developed countries, where the prevalence of disease and the need for effective vaccines outweighs the risk associated with their administration, live vaccines may play an important role in human health. This review has attempted to make the reader aware of some of the current approaches and issues that are associated with the development of these vaccines. Genetically engineered vaccines hold great promise for the future, but the potential of these vaccines to improve human and animal health has yet to be fully realized.
Genetically engineered vaccines: an overview - PubMed
Despite the early success demonstrated with the hepatitis B vaccine, no other recombinant engineered vaccine has been approved for use in humans. It is unlikely that a recombinant vaccine will be developed to replace an existing licensed human vaccine with a proven record of safety and efficacy...pubmed.ncbi.nlm.nih.gov
Gwajima aliulizwa maswali na wananchi wa kawe kipindi cha kampeni kuhusu majukumu ya mbunge ambayo ni nafasi aliyokuwa anaigombea na akashindwa,Sasa kwenye chanjo ataongelea nn zaid ya upuuzi?Hivi unaweza kupoteza muda wako kumjibu Gwajima! labda asiyemfahamu ( Treni, Vijana kuwapeleka ulaya, nk.) Labda watu wa aina ya sabato masalia wanaweza kujaribu